AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3684395 — intervention group
Group type: EXPERIMENTAL
Intervention: Research breast-feeding bedside counseling by a trained counselor with eight telephone calls during the first 3 months
Number of subjects: 343
Study 3684395 — intervention group
Group type: EXPERIMENTAL
Intervention: Research discharge pack
Number of subjects: 343
Study 3684395 — intervention group
Group type: EXPERIMENTAL
Intervention: Research counseling with research discharge pack
Number of subjects: 343
Study 3684395 — intervention group
Group type: COMPARATOR
Intervention: Routine breast-feeding counseling provided in the hospital by nurses
Number of subjects: 343
Study 3684395 — intervention group
Group type: COMPARATOR
Intervention: Commercial discharge pack
Number of subjects: 343
Study 31987331 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (300 mg/kg)
Number of subjects: 128
Study 31987331 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (600 mg/kg)
Number of subjects: 128
Study 31987331 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental CoQ10 (900 mg/kg)
Number of subjects: 128
Study 31987331 — intervention group
Group type: COMPARATOR
Intervention: No CoQ10 supplementation
Number of subjects: 128
Study 29970155 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint herbal plaster (AHP) using Shaofuzhuyu decoction on acupoints Shenque (CV8), Guanyuan (CV4), Qihai (CV5), Ciliao (BL32), and Zigong (EX-CA1)
Number of subjects: 180
Study 29970155 — intervention group
Group type: COMPARATOR
Intervention: Acupoint placebo plaster (APP) on the same acupoints
Number of subjects: 180
Study 29970155 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (WL) with no intervention
Number of subjects: 180
Study 28784280 — intervention group
Group type: EXPERIMENTAL
Intervention: PnCj-PPS group
Number of subjects: 42
Study 28784280 — intervention group
Group type: COMPARATOR
Intervention: Placebo-PPS group
Number of subjects: 42
Study 26158926 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (Catalys; Abbott Medical Optics)
Number of subjects: 29
Study 26158926 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 29
Study 24050486 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion text message group
Number of subjects: 120
Study 24050486 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention text message group
Number of subjects: 120
Study 24050486 — intervention group
Group type: COMPARATOR
Intervention: Attention-control text message group
Number of subjects: 120
Study 21967909 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed, unfolded cotton sheet and cotton blanket
Number of subjects: 578
Study 21967909 — intervention group
Group type: COMPARATOR
Intervention: Two folded, warmed cotton blankets
Number of subjects: 578
Study 17911541 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 0
Study 17911541 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study 15377061 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination dietary supplement
Number of subjects: 27
Study 15377061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11474254 — intervention group
Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, 5-fluorouracil)
Number of subjects: 145
Study 11474254 — intervention group
Group type: EXPERIMENTAL
Intervention: CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil)
Number of subjects: 145
Study 9734807 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated refractor (Hoya AR-570)
Number of subjects: 86
Study 9734807 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective refraction by clinicians
Number of subjects: 86
Study 9734807 — intervention group
Group type: COMPARATOR
Intervention: Automated refractor
Number of subjects: 86
Study 8046120 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg capsules)
Number of subjects: 161
Study 8046120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (5 mg from vial)
Number of subjects: 161
Study 2929467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate-responsive pacing
Number of subjects: 10
Study 2929467 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 10
Study 29483185 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0
Study 29483185 — intervention group
Group type: COMPARATOR
Intervention: Basal-Bolus Insulin
Number of subjects: 0
Study 26969308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling (TC)
Number of subjects: 479
Study 26969308 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC; in-person) genetic counseling
Number of subjects: 479
Study 25096690 — intervention group
Group type: COMPARATOR
Intervention: No brief intervention
Number of subjects: 528
Study 25096690 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Negotiated Interview (BNI)
Number of subjects: 528
Study 25096690 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MOTIV)
Number of subjects: 528
Study 22739369 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplements (5 g/d, 2 g EPA, 1 g DHA)
Number of subjects: 116
Study 22739369 — intervention group
Group type: COMPARATOR
Intervention: Corn/soy oil (PL) (5 g/d)
Number of subjects: 116
Study 20604814 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy with 80 mg Tokyo strain BCG instillation once weekly for eight consecutive weeks.
Number of subjects: 90
Study 20604814 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with four additional BCG instillations after achieving CR.
Number of subjects: 90
Study 20604814 — intervention group
Group type: COMPARATOR
Intervention: Observation group (control) after induction therapy.
Number of subjects: 90
Study 20604814 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy with BCG.
Number of subjects: 90
Study 20604814 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with BCG.
Number of subjects: 90
Study 20604814 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction and maintenance therapy with BCG.
Number of subjects: 90
Study 17428617 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 81
Study 17428617 — intervention group
Group type: COMPARATOR
Intervention: Education control
Number of subjects: 81
Study 16554456 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/d) for 18 days
Number of subjects: 20
Study 16554456 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/d) coadministered in the last 4 study days
Number of subjects: 20
Study 16554456 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine and Aspirin combination
Number of subjects: 20
Study 16554456 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 20
Study 12765282 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour-based segmentation algorithm
Number of subjects: 0
Study 12765282 — intervention group
Group type: EXPERIMENTAL
Intervention: Edge detector
Number of subjects: 0
Study 12765282 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm evaluation
Number of subjects: 0
Study 10670114 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.05 mg/kg
Number of subjects: 60
Study 10670114 — intervention group
Group type: EXPERIMENTAL
Intervention: vecuronium 0.007 mg/kg
Number of subjects: 60
Study 10670114 — intervention group
Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 60
Study 10670114 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 9078354 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg (500 mg/kg/month)
Number of subjects: 250
Study 1856146 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin once daily (6.6 mg/kg)
Number of subjects: 60
Study 1856146 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin once daily (14.5 mg/kg)
Number of subjects: 60
Study 1856146 — intervention group
Group type: COMPARATOR
Intervention: Netilmicin thrice daily (tid)
Number of subjects: 60
Study 1856146 — intervention group
Group type: COMPARATOR
Intervention: Netilmicin twice daily (bd)
Number of subjects: 60
Study 1856146 — intervention group
Group type: COMPARATOR
Intervention: Amikacin twice daily (bd)
Number of subjects: 60
Study 1856146 — intervention group
Group type: COMPARATOR
Intervention: All regimens (including lower frequencies)
Number of subjects: 60
Study 6611665 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps femoris muscle setting
Number of subjects: 40
Study 6611665 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight leg raise
Number of subjects: 40
Study 30999989 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG in EXCEL trial
Number of subjects: 909
Study 30999989 — intervention group
Group type: COMPARATOR
Intervention: CABG in SYNTAX trial
Number of subjects: 909
Study 30650281 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL)
Number of subjects: 162
Study 30650281 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based learning (LBL)
Number of subjects: 162
Study 25904781 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive working memory training
Number of subjects: 0
Study 24698485 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg once daily
Number of subjects: 484
Study 24698485 — intervention group
Group type: COMPARATOR
Intervention: Darunavir 800 mg plus ritonavir 100 mg once daily
Number of subjects: 484
Study 24698485 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 484
Study 24698485 — intervention group
Group type: COMPARATOR
Intervention: Darunavir plus ritonavir
Number of subjects: 484
Study 23000845 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 64
Study 19317821 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled insulin (AERx iDMS)
Number of subjects: 304
Study 19317821 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin (s.c.)
Number of subjects: 304
Study 17613977 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 session intervention
Number of subjects: 171
Study 17613977 — intervention group
Group type: COMPARATOR
Intervention: Delayed-intervention condition
Number of subjects: 171
Study 15258698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cisplatin (10‐30 mg/m2)
Number of subjects: 32
Study 15258698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cisplatin (30‐min infusions)
Number of subjects: 32
Study 15258698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cisplatin
Number of subjects: 32
Study 15258698 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbound platinum
Number of subjects: 32
Study 11739089 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-fat recovery diet (35% of energy, MFAT)
Number of subjects: 7
Study 11739089 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-fat recovery diet (10% of energy, LFAT)
Number of subjects: 7
Study 11739089 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance run (2-h treadmill run at 67% of VO2 max)
Number of subjects: 7
Study 10561263 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionated radiation therapy (ACC HFX RT) with 54 Gy in 36 fractions over 18 treatment days plus concurrent daily carboplatin/etoposide (CE) (group 1, n = 55)
Number of subjects: 210
Study 10561263 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin/etoposide (PE) chemotherapy alone (group 2, n = 54)
Number of subjects: 210
Study 10150495 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 micrograms) with HFA134a
Number of subjects: 0
Study 10150495 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms, 100 micrograms) with HFA134a
Number of subjects: 0
Study 10150495 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (HFA134a) used as required
Number of subjects: 0
Study 10150495 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol (50 micrograms) twice daily with HFA134a
Number of subjects: 0
Study 10150495 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) (250 micrograms) twice daily with HFA134a
Number of subjects: 0
Study 2285609 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 30 mg/day + Bromocriptine (B) 5 mg/day
Number of subjects: 171
Study 2285609 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (TAM) 30 mg/day + Placebo
Number of subjects: 171
Study 7029648 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2 0.04 mg four times daily
Number of subjects: 32
Study 7029648 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2 0.25 mg four times daily
Number of subjects: 32
Study 7029648 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2 0.5 mg four times daily
Number of subjects: 32
Study 7029648 — intervention group
Group type: COMPARATOR
Intervention: ASA (650 mg four times daily)
Number of subjects: 32
Study 30280324 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching tray (White Class, FGM)
Number of subjects: 60
Study 30280324 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitening strips (White Strips, Oral-b)
Number of subjects: 60
Study 30280324 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefilled disposable trays (Opalescence Go, Ultradent)
Number of subjects: 60
Study 27891632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg for 8 weeks (GU study)
Number of subjects: 456
Study 27891632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg for 6 weeks (DU study)
Number of subjects: 456
Study 27891632 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg for 8 weeks (GU study)
Number of subjects: 456
Study 27891632 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg for 6 weeks (DU study)
Number of subjects: 456
Study 25010152 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 26
Study 25010152 — intervention group
Group type: COMPARATOR
Intervention: Sham taping
Number of subjects: 26
Study 24094310 — intervention group
Group type: EXPERIMENTAL
Intervention: Central hole myopic contact lens
Number of subjects: 10
Study 24094310 — intervention group
Group type: COMPARATOR
Intervention: Non-hole contact lens
Number of subjects: 10
Study 21936957 — intervention group
Group type: EXPERIMENTAL
Intervention: Skill-building intervention
Number of subjects: 500
Study 21936957 — intervention group
Group type: EXPERIMENTAL
Intervention: Price reductions on fruits, vegetables, low-joule soft drinks, and water
Number of subjects: 500
Study 21936957 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of skill-building and price reductions
Number of subjects: 500
Study 21936957 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 500
Study 18347178 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen-based therapy (ABCSG Trial 05)
Number of subjects: 1201
Study 18347178 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen-based therapy (ABCSG Trial 06)
Number of subjects: 1201
Study 16686873 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient report of change in depressive symptoms using Clinical Global Impressions of Change (CGI-C)
Number of subjects: 56
Study 16686873 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient report of at least 'much improved'
Number of subjects: 56
Study 14552520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse advice service
Number of subjects: 1182
Study 14552520 — intervention group
Group type: COMPARATOR
Intervention: On-call pediatricians
Number of subjects: 1182
Study 10761165 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS (methylphenidate HCl) 18 mg qd
Number of subjects: 0
Study 10761165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) methylphenidate 20 mg qd
Number of subjects: 0
Study 10761165 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) formulation (three 5 mg doses every 4 hours)
Number of subjects: 0
Study 10761165 — intervention group
Group type: COMPARATOR
Intervention: OROS (methylphenidate HCl)
Number of subjects: 0
Study 8598756 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐oestradiol 200 micrograms daily for 3 months, then 3 months with added cyclical dydrogesterone 10mg daily for 12 days each month
Number of subjects: 61
Study 8598756 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches and tablets according to the same regimen
Number of subjects: 61
Study 1428436 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil 2%
Number of subjects: 33
Study 1428436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 3903070 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (1000 mg bolus and 1000 mg daily for 10 days)
Number of subjects: 0
Study 3903070 — intervention group
Group type: COMPARATOR
Intervention: Standard dose methylprednisolone (100 mg bolus and 100 mg daily for 10 days)
Number of subjects: 0
Study 29938626 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxious-mood induction
Number of subjects: 22
Study 29938626 — intervention group
Group type: COMPARATOR
Intervention: Neutral-mood induction
Number of subjects: 22
Study 29297950 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg vaginal progesterone
Number of subjects: 30
Study 29297950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 26945226 — intervention group
Group type: EXPERIMENTAL
Intervention: Active peripheral nerve stimulation
Number of subjects: 19
Study 26945226 — intervention group
Group type: COMPARATOR
Intervention: Sham peripheral nerve stimulation
Number of subjects: 19
Study 23911112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD; n=22)
Number of subjects: 46
Study 23911112 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet + orlistat (LFD + O; n=24)
Number of subjects: 46
Study 23146983 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram, 20 mg/d for 3 months
Number of subjects: 44
Study 23146983 — intervention group
Group type: COMPARATOR
Intervention: Psychological training (6 sessions of 1-hour each)
Number of subjects: 44
Study 23146983 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Citalopram and Psychological training
Number of subjects: 44
Study 19918017 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 11
Study 19918017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 19918017 — intervention group
Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 11
Study 18819472 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tacrolimus
Number of subjects: 58
Study 18819472 — intervention group
Group type: COMPARATOR
Intervention: Model building group (n=41)
Number of subjects: 58
Study 18819472 — intervention group
Group type: COMPARATOR
Intervention: Validation group (n=17)
Number of subjects: 58
Study 17092654 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological assessments before and after biopsy
Number of subjects: 0
Study 17092654 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural killer (NK) cell activity and INF gamma production
Number of subjects: 0
Study 17092654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine production (IL‐4, IL‐6, IL‐10)
Number of subjects: 0
Study 15497661 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (Osalen 10 mg tablets)
Number of subjects: 89
Study 15497661 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (originator product)
Number of subjects: 89
Study 15497661 — intervention group
Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 89
Study 11273926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-Track group (bypassed PACU, directly admitted to SSRU)
Number of subjects: 155
Study 11273926 — intervention group
Group type: COMPARATOR
Intervention: Control group (admitted to PACU then SSRU)
Number of subjects: 155
Study 11273926 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-Track group
Number of subjects: 155
Study 11273926 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study 9290451 — intervention group
Group type: EXPERIMENTAL
Intervention: Coculture with buffalo rat liver cells
Number of subjects: 203
Study 9290451 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coculture)
Number of subjects: 203
Study 8318320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% infused at 5 ml h‐1
Number of subjects: 20
Study 8318320 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 20
Study 8318320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine infusion
Number of subjects: 20
Study 3711963 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 68
Study 3711963 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 68
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragility Index (FI)
Number of subjects: 32
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragility Quotient (FQ)
Number of subjects: 32
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: P-value
Number of subjects: 32
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients lost to follow up
Number of subjects: 32
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between FI and P-value
Number of subjects: 32
Study 31851082 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between FI and sample size
Number of subjects: 32
Study 31051087 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mmol sodium nitrate
Number of subjects: 10
Study 31051087 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mmol sodium nitrate
Number of subjects: 10
Study 31051087 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mmol sodium nitrate
Number of subjects: 10
Study 31051087 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 10
Study 29533264 — intervention group
Group type: COMPARATOR
Intervention: Major Adverse Cardiac Events (MACEs)
Number of subjects: 6992
Study 29533264 — intervention group
Group type: COMPARATOR
Intervention: Major Adverse Postoperative Events (MAPEs) without troponin elevation
Number of subjects: 6992